De-Francesco E M,？ Lappano R,？ Santolla M F,？ et al. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)[J]. Breast Cancer Res,？ 2013,？ 15(4):？ R64.？ [2]Yu T,？ Liu M,？ Luo H,？ et al. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells[J]. J Steroid Biochem Mol Biol,？ 2014,？ 143:？ 392-403.？ [3]Mo Z,？ Liu M,？ Yang F,？ et al. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer[J]. Breast Cancer Res,？ 2013,？ 15(6):？ R114.？ [4]Luo H,？ Yang G,？ Yu T,？ et al. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts[J]. Endocr Relat Cancer,？ 2014,？ 21(2):？ 355-369.？ [5]Mantovani A,？ Allavena P,？ Sica A,？ et al. Cancer-related inflammation[J]. Nature,？ 2008,？ 454(7203):？ 436-444.？ [6]He Y Y,？ Cai B,？ Yang Y X,？ et al. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation,？ invasion potential,？ and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway[J]. Cancer Sci,？ 2009,？ 100(6):？ 1051-1061. [7]Bologa C G,？ Revankar C M,？ Young S M,？ et al. Virtual and biomolecular screening converge on a selective agonist for GPR30[J]. Nat Chem Biol,？ 2006,？ 2(4):？ 207-212.？ [8]Dennis M K,？ Burai R,？ Ramesh C,？ et al. In vivo effects of a GPR30 antagonist[J]. Nat Chem Biol,？ 2009,？ 5(6):？ 421-427.？ [9]Blaskovich M A,？ Sun J,？ Cantor A,？ et al. Discovery of JSI-124 (cucurbitacin I),？ a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice[J]. Cancer Res,？ 2003,？ 63(6):？ 1270-1279. [10]Luo F,？ Xu Y,？ Ling M,？ et al. Arsenite evokes IL-6 secretion,？ autocrine regulation of STAT3 signaling,？ and miR-21 expression,？ processes involved in the EMT and malignant transformation of human bronchial epithelial cells[J]. Toxicol Appl Pharmacol,？ 2013,？ 273(1):？ 27-34.？ [11]Choi Y K,？ Cho S G,？ Woo S M,？ et al. Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling[J]. Mediators Inflamm,？ 2014,？ 2014:？ 492173.？ [12]Kumar J,？ Ward A C. Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications[J]. Biochim Biophys Acta,？ 2014,？ 1845(2):？ 117-125.？ [13]Cho Y A,？ Sung M K,？ Yeon J Y,？ et al. Prognostic role of interleukin-6,？ interleukin-8,？ and leptin levels according to breast cancer subtype[J]. Cancer Res Treat,？ 2013,？ 45(3):？ 210-219.？ [14]Binai N A,？ Damert A,？ Carra G,？ et al. Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells[J]. Int J Cancer,？ 2010,？ 127(1):？ 55-66.？ [15]Jiang Q F,？ Wu T T,？ Yang J Y,？ et al. 17β-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1[J]. J Steroid Biochem Mol Biol,？ 2013,？ 138:？ 314-324.？ [16]余腾骅, 罗浩军, 严玉钊, 等. GPR30介导雌激素对三阴性乳腺癌MDA-MB-468细胞系增殖的影响[J]. 第三军医大学学报,？ 2014,？ 36(14):？ 1467-1471.
[2]
张沁舒,方毅,王力,等.大七气汤对大鼠子宫内膜异位症P450与COX-2表达的影响[J].第三军医大学学报,2012,34(21):2167. Zhang Qinshu,Fang Yi,Wang Li,et al.Effect of Da Qiqi decoction on expression of P450 and COX-2 in endometriosis of rats[J].J Third Mil Med Univ,2012,34(04):2167. [2]李维东,罗浩军,李振华,等.雌激素激活GPER-EGFR-ERK通路促进人乳腺癌SKBR-3细胞系增殖[J].第三军医大学学报,2012,34(22):2283. Li Weidong,Luo Haojun,Li Zhenhua,et al.Estrogen activates GPER-EGFR-ERK pathway to promote the proliferation of human breast cancer cell line SKBR-3[J].J Third Mil Med Univ,2012,34(04):2283. [3]胡荣,吴喜贵,杨忠,等.大鼠星形胶质细胞源性的雌激素对突触传递功能调节的实验研究[J].第三军医大学学报,2006,28(04):279. [4]吴婷婷,龙方懿,贾朝莉,等.G蛋白偶联受体在雌激素诱导人甲状腺未分化癌FRO细胞增殖中的作用及其机制[J].第三军医大学学报,2011,33(02):164. Wu Tingting,Long Fangyi,Jia Chaoli,et al.G-protein coupled receptor improves 17β-Estradiol induced proliferation of human anaplastic thyroid carcinoma FRO cells[J].J Third Mil Med Univ,2011,33(04):164. [5]甘长清,王小毅.经动脉灌注新辅助化疗对局部进展期乳腺癌激素受体表达水平的上调作用[J].第三军医大学学报,2009,31(18):1794. GAN Chang-qing,WANG Xiao-yi.Transarterial infusion neoadjuvant chemotherapy up-regulates expressions of hormone receptors in local advanced breast cancer tissues[J].J Third Mil Med Univ,2009,31(04):1794. [6]孙欣慰,杨铧琦,徐惠成.17β-雌二醇通过上调CXCR4表达促进骨髓间充质干细胞的趋化迁移[J].第三军医大学学报,2014,36(07):664. Sun Xinwei,Yang Huaqi,Xu Huicheng.17β-estradiol promotes chemotaxis migration of bone mesenchymal stem cells by up-regulating CXCR4[J].J Third Mil Med Univ,2014,36(04):664. [7]余腾骅,罗浩军,严玉钊,等.GPR30介导雌激素对三阴性乳腺癌MDA-MB-468细胞系增殖的作用[J].第三军医大学学报,2014,36(14):1467. Yu Tenghua,Luo Haojun,Yan Yuzhao,et al.Effects of estrogen on GPR30-mediated proliferation in triple-negative breast cancer cell line MDA-MB-468[J].J Third Mil Med Univ,2014,36(04):1467. [8]祝红,王攀,黄良国,等.帕罗西汀与克龄蒙联合治疗围绝经期抑郁症5-羟色胺、雌二醇变化及疗效观察[J].第三军医大学学报,2014,36(14):1531. [9]魏璐,蔡文琴,杨忠.雌激素对癫痫大鼠海马区胶质细胞增生和突触可塑性变化的影响[J].第三军医大学学报,2006,28(04):327.
